Clinical Pharmacology & Biopharmaceutics
Open Access

Commentary

The Use of H2-Blockers in Intensive Care

Department of Medicine, Grodno State Medical University, Grodno, USA

*Corresponding Author:

Prabhjot Kaur
Department of Medicine, Grodno State Medical University
Grodno, USA
Tel: +375-152-435561
E-mail: drprabhjotkaur@hotmail.com

Received date: August 21, 2017; Accepted date: August 29, 2017; Published date: August 31, 2017

Citation: Kaur P, Mukherjee A, Rutkevich AS, Rutkevich EU, Predko VA, et al. (2017) The Use of H2-Blockers in Intensive Care. Clin Pharmacol Biopharm 6:176. doi: 10.4172/2167-065X.1000176

Copyright: © 2017 Kaur P, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Treatment plan for a patient in ICU is quite complicated as doctors from different specialities take part in it with advanced methods and machines. But the intensive treatment and diseases of the patient also has complications in itself.

Keywords